| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |